Business
CB Scientific (CBSC) is Launching CannaRAPID, a Novel Sublingual Product for Precise Cannabinoid Dosing -- Optimized with Nanotechnology and Tissue Permeation Enhancing Molecules for Faster Absorption
CB Scientific (CBSC) is Launching CannaRAPID, a Novel Sublingual Product for Precise Cannabinoid Dosing -- Optimized with Nanotechnology and Tissue Permeation Enhancing Molecules for Faster Absorption.
About this update from Cardiac Biotech Solutions Inc.
[{"type":"text","content":"\n \n \n CB Scientific (CBSC) is Launching CannaRAPID, a Novel Sublingual Product for Precise Cannabinoid Dosing -- Optimized with Nanotechnology and Tissue Permeation Enhancing Molecules for Faster Absorption\n \n \nCB Scientific (CBSC) is Launching CannaRAPID, a Novel Sublingual Product for Precise Cannabinoid Dosing -- Optimized with Nanotechnology and Tissue Permeation Enhancing Molecules for Faster Absorption\n \n DENVER, CO--(Marketwired - May 15, 2017) -  CB Scientific, Inc. (OTC PINK: CBSC), a designer, developer and manufacturer of Cannabis Analytical Tools and Devices, Cannabis Medical Delivery Systems and Personal Analytical Kits and Devices, announces today that the Company has developed a novel product medical device portfolio since acquiring Marutronics Medical Devices in February 2017. The company has developed three core platform technologies; CannaRAPID™, CannaNASAL™, and CannaDERME™, focused on precise dosing and controlled release of cannabinoid compounds for patients. CB Scientific's will be launching CannaRAPID, a sublingual cannabinoid delivery product, at the end of May 2017.\n Why CB Scientific Developed CannaRAPID™ \n There are several inherent benefits of sublingual delivery of drugs such as fast absorption, avoidance of unwanted liver and gut microbiota metabolism on active drug. Further, as medical cannabis is going to be on mainstream medicine, there is an urgent need for a new dosage and delivery form that can improve patient compliance. Common complaints about the difficulty in swallowing tablets in the order of frequency of complaints are size, surface, form, and taste of tablets are common in various patient groups. Geriatric and pediatric patients and traveling patients who may not have ready access to water are most in need of easy swallowing dosage forms.\n \"Almost 50% of people suffer from some form of dysphagia, or difficulty in swallowing,\" said Bobban Subhadra, M.S., Ph.D., Chief Operating Officer of CB Scientific. \"Solid dosage forms that can be dissolved or suspended with water in the mouth for easy swallowing are highly desirable for the pediatric and geriatric population, as well as other patients who prefer the convenience of readily administered dosage forms, and that is reason why we come up with CannaRAPID,\" he added.\n CB Scientific's sublingual pr...